Screening and subcloning of high producer transfectomas using semisolid media and automated colony picker.

Generation of high-producing clones is a perquisite for achieving recombinant protein yields suitable for biopharmaceutical production. However, in many industrially important cell lines used to produce recombinant proteins such as Chinese hamster ovary, mouse myeloma line (NS0), and hybridomas, only a minority of clones show significantly above-average productivity. Thus, in order to have a reasonable probability of finding rare high-producing clones, a large number of clones need to be screened. Limiting dilution cloning is the most commonly used method, owing to its relative simplicity and low cost. However the use of liquid media in this method makes the selection of monoclonal hybridoma and transfectoma colonies to be labor intensive and time consuming, thus significantly limiting the number of clones that can be feasibly screened. Hence, we describe the use of semisolid media to immobilize clones and a high-throughput, automated colony picker (ClonePix FL) to efficiently isolate monoclonal high-producing clones secreting monoclonal antibodies.

[1]  R. Pérez,et al.  Humanization of predicted T-cell epitopes reduces the immunogenicity of chimeric antibodies: new evidence supporting a simple method. , 2003, Hybridoma and hybridomics.

[2]  Noelle-Ann Sunstrom,et al.  High-throughput clonal selection of recombinant CHO cells using a dominant selectable and amplifiable metallothionein-GFP fusion protein. , 2002, Biotechnology and bioengineering.

[3]  R Staszewski,et al.  Murphy's law of limiting dilution cloning. , 1990, Statistics in medicine.

[4]  Mohamed Al-Rubeai,et al.  Selection methods for high-producing mammalian cell lines. , 2007, Trends in biotechnology.

[5]  H. Chong,et al.  Rapid automated selection of mammalian cell line secreting high level of humanized monoclonal antibody using Clone Pix FL system and the correlation between exterior median intensity and antibody productivity , 2011 .

[6]  A. Dickson,et al.  Mammalian cell factories for efficient and stable protein expression. , 2006, Current opinion in biotechnology.

[7]  A. Garnier,et al.  Fluorescent labeling in semi-solid medium for selection of mammalian cells secreting high-levels of recombinant proteins , 2009, BMC biotechnology.

[8]  M. Al‐Rubeai,et al.  ACSD labelling and magnetic cell separation: a rapid method of separating antibody secreting cells from non-secreting cells. , 2005, Journal of immunological methods.

[9]  G. Lee,et al.  Key Determinants in the Occurrence of Clonal Variation in Humanized Antibody Expression of CHO Cells during Dihydrofolate Reductase Mediated Gene Amplification , 2001, Biotechnology progress.

[10]  P. Underwood,et al.  Hazards of the limiting-dilution method of cloning hybridomas. , 1988, Journal of immunological methods.

[11]  J. Coloma,et al.  Removal of amphipathic epitopes from genetically engineered antibodies: production of modified immunoglobulins with reduced immunogenicity. , 2000, Hybridoma.